Australia Pet Gut Health Market

Overview

The Australia Pet Gut Health Market was valued at USD 172.6 Million in 2025 and is projected to reach USD 368.4 Million by 2034, growing at a CAGR of 8.9% during the forecast period (2026-2034). The market is driven by rising pet ownership across Australian households, greater veterinary and pet-owner awareness of the gut-immune connection, and expanding premiumisation of dog and cat nutrition toward science-led, microbiome-targeted formulations. The market is shifting from conventional, single-strain probiotic powders sold mainly through veterinary clinics toward multi-strain synbiotic and postbiotic formats that combine live or heat-stabilised cultures with prebiotic fibre and digestive enzymes in a single product, often built around native Australian functional ingredients such as Kakadu plum. Government and industry initiatives such as the Pet Food Industry Association of Australia's reinforcement of Australian Standard AS 5812 for pet food manufacturing, labelling and safety, together with Food Standards Australia New Zealand ingredient guidance and Australian Pesticides and Veterinary Medicines Authority oversight of veterinary feed additives, are shaping how gut health claims and probiotic strains are formulated, manufactured and marketed to Australian pet owners. By region, New South Wales held the dominating share of the Australia Pet Gut Health Market in 2025, supported by its large pet-owning population and concentration of pet nutrition manufacturing, while Queensland is projected to be the fastest-growing region through 2034 on the back of above-average population and pet-ownership growth.

Market Size & Share

Market Dynamics

KEY MARKET TREND

Postbiotic and Synbiotic Innovation Reshaping Australia's Pet Gut Health Category

• Australian formulators are moving beyond single-strain probiotic powders toward heat-stabilised postbiotic and combined synbiotic formats that remain effective without refrigeration. Sydney-based Ipromea has built its range around Zoonatant, a patented postbiotic technology designed to seal the intestinal barrier and modulate the gut environment in dogs and cats.
• Native Australian botanicals are being paired with fermentation-derived ingredients to differentiate local formulations from imported products. Melbourne pet food brand Talentail has built its kibble and treat range around Kakadu plum alongside postbiotics and prebiotics, positioning native antioxidant-rich ingredients as a point of local differentiation in gut-focused nutrition.
• Established multi-strain powder brands are being reformulated with additional spore-forming bacterial strains to improve shelf stability and stool-quality outcomes. Blackmores' PAW DigestiCare range, for example, combines multi-strain probiotics with fermented wholefoods and digestive enzymes, reflecting a broader move toward multi-mechanism gut support rather than single-ingredient powders.
• A January 2026 peer-reviewed review published in the journal Animal Microbiome synthesised current evidence on the gut microbiome of Australian cats and dogs, confirming that Firmicutes, Bacteroidetes, Proteobacteria and Actinobacteria dominate the canine and feline gut while identifying the need for region-specific microbial baselines to guide future Australian product development.

KEY MARKET DRIVER

Rising Companion-Animal Ownership and a Preventive-Care Mindset are Driving Structured Gut Health Adoption

• Nearly seven in ten Australian households now own a pet, and owners are increasingly treating digestive wellbeing as a preventive-care priority rather than only responding once diarrhoea, bloating or food sensitivities appear. Veterinary professionals and pet nutritionists are actively educating owners that up to seventy per cent of a dog's immune cells are located in the gut, reinforcing daily gut-support routines.
• Rising cat ownership is broadening the driver base beyond dogs, with Mars Petcare noting cat ownership in Australia growing at close to four per cent annually, faster than dog ownership. This is lifting demand for feline-specific gut formats, including brush-free oral-and-gut probiotic powders from brands such as Sydney-based Purrlys.
• Premiumisation of everyday pet nutrition is pulling gut-health ingredients into mainstream dry and wet food, not just supplements, as owners trade up from basic diets to formulas featuring prebiotic fibre and digestive-enzyme technology. This mirrors the broader premium pet-food trend, in which Australians already direct a substantial share of household pet spending toward higher-value nutrition.
• The Pet Food Industry Association of Australia reinforced compliance guidance around Australian Standard AS 5812 in August 2025, directly linking pet food safety and manufacturing standards to gut microbiome health messaging for pet owners, which is strengthening consumer trust in locally manufactured gut-health claims.

KEY MARKET OPPORTUNITY

Native Ingredient Differentiation and Veterinary-to-Retail Channel Expansion are Creating New Growth Avenues

• Australian-made brands have an opportunity to differentiate globally sourced probiotic strains with native functional botanicals such as Kakadu plum, green-lipped mussel and kangaroo protein, building export-ready positioning while meeting rising domestic demand for locally sourced, traceable ingredients in gut-health formulations.
• Products historically confined to veterinary clinics are increasingly available through pet specialty retail and direct-to-consumer online channels, widening the addressable market for paste and powder formats such as Protexin Veterinary's Pro-Kolin range, which is now stocked nationally through major veterinary wholesalers as well as online pet pharmacies.
• Contract manufacturers such as ProbioWorld Group are lowering the barrier for smaller Australian brands to launch TGA- and GMP-compliant probiotic and postbiotic pet products, opening the category to new entrants that previously lacked in-house formulation and regulatory capability, and accelerating the pace of new product introductions.
• Global ingredient suppliers are expanding pet-specific probiotic platforms that Australian formulators can access through regional distribution. Swedish probiotics group Probi AB launched Pets by Probi in November 2025, a digestive- and oral-health ingredient platform built on its LP6595 strain, widening the pool of clinically studied strains available to Australian contract manufacturers and private-label brands. 

Australia Pet Gut Health Market Size, 2025-2034 (USD Million)

Segmentation Analysis

Analysis by Product Type

Probiotics held the largest share of the Australia Pet Gut Health Market by product type in 2025, supported by decades of veterinary familiarity with live-culture powders and pastes such as Protexin's Pro-Kolin and Natural Animal Solutions' Gut Balance formula. Their established clinical use for acute diarrhoea, post-antibiotic recovery and general digestive maintenance gives probiotics the broadest retail footprint across veterinary clinics, pet specialty stores and pharmacies. Multi-strain formulations combining Lactobacillus, Bifidobacterium and Enterococcus species remain the reference standard that Australian veterinarians recommend first, reinforcing probiotics' position as the anchor product type from which prebiotic, postbiotic and synbiotic innovation has subsequently expanded.

Postbiotics are projected to expand at the fastest CAGR through 2034, as heat-stabilised bacterial metabolites overcome the cold-chain and shelf-stability limitations that constrain live probiotic cultures in Australia's warm climate and long domestic supply routes. Ipromea's patented Zoonatant technology and Talentail's postbiotic pet food range illustrate growing manufacturer confidence in postbiotics' anti-inflammatory and barrier-sealing properties. As veterinary evidence for postbiotic efficacy accumulates and shelf-stable formats reduce distribution costs for regional and remote retailers, postbiotics are increasingly positioned as the next-generation alternative to conventional probiotic powders across both wellness and therapeutic use cases.

Product Type categories include

• Probiotics (Dominating Segment)
• Postbiotics (Highest CAGR Segment)
• Prebiotics
• Synbiotics
• Digestive Enzymes

Analysis by Form

Powder formats held the largest share of the market in 2025, reflecting their dominance across both veterinary-recommended and mass-retail gut health products in Australia, including PAW DigestiCare, NAS Gut Balance Probiotic and Vitamals' Dog Gut Health powder. Powders offer accurate dose adjustment by bodyweight, straightforward mixing into daily meals, and comparatively lower unit costs than paste or capsule formats, making them the default recommendation for everyday maintenance use. Their compatibility with both dry and wet diets, together with long-standing familiarity among Australian veterinarians, continues to anchor powder as the leading delivery format across the category.

Chews and treats are forecast to record the fastest CAGR to 2034 as Australian pet owners increasingly favour palatable, treat-like formats that combine health benefits with everyday bonding moments over powders that must be measured and mixed. Vetalogica's Canine Prodigestive Ultra chewable range exemplifies this shift toward grain-free, naturally flavoured digestive support that pets readily accept without disguising it in food. As manufacturers refine prebiotic and enzyme stability in baked and soft-chew matrices, chews and treats are closing the efficacy gap with powders while offering superior compliance for fussy eaters and multi-pet households.

Form categories include

• Powder (Dominating Segment)
• Chews and Treats (Highest CAGR Segment)
• Paste
• Gel
• Capsules
• Tablets
• Functional Food

Analysis by Pet Type

Dogs accounted for the largest share of the Australia Pet Gut Health Market in 2025, reflecting both Australia's larger dog-owning population relative to cats and dogs' greater susceptibility to dietary indiscretion, scavenging and diet-change-related digestive upset. The breadth of dog-specific gut health formats, from Sasha's-style powders to Royal Canin's veterinary Gastrointestinal diets, gives dog owners far more choice than is currently available for cats, reinforcing dogs' lead position across both preventive and therapeutic use cases in veterinary clinics and pet specialty retail nationwide.

Cats are projected to post the fastest CAGR through the forecast period as feline-specific gut and oral microbiome products move from a niche afterthought to a defined category, led by Australian brands such as Purrlys, which combines gut and oral probiotic support in a tasteless, brush-free powder. Rising cat ownership, longer feline lifespans that increase exposure to chronic digestive conditions, and growing veterinary recognition that feline gastrointestinal disease is frequently under-diagnosed are together accelerating demand for cat-specific formulations distinct from repackaged canine products.

Pet Type categories include

• Dogs (Dominating Segment)
• Cats (Highest CAGR Segment)
• Other Companion Animals

Analysis by Distribution Channel

Veterinary clinics held the largest share of channel distribution in 2025, as therapeutic gut health products such as Royal Canin Gastrointestinal, Purina Pro Plan EN Gastrointestinal and Hill's Prescription Diet i/d with ActivBiome+ technology are formulated for use under veterinary supervision and are typically first recommended following a clinical diagnosis. The clinic channel benefits from direct veterinarian endorsement, which remains the single most trusted source of product information for Australian pet owners managing an unwell pet, reinforcing its leading position for higher-value therapeutic formulations.

Online retail is expected to expand at the fastest CAGR to 2034, as subscription-based auto-delivery models offered by Australian pet e-commerce platforms make ongoing gut-health supplementation more convenient than repeat in-store or in-clinic purchases. Brands including ZamiPet, Petz Park and Natural Pet Supplements Australia now sell directly to consumers online, while established veterinary retailers have expanded e-pharmacy operations, allowing Australian pet owners in regional and remote areas equal access to products that were previously available only through metropolitan veterinary clinics.

Distribution Channel categories include

• Veterinary Clinics (Dominating Segment)
• Pet Specialty Stores
• Online Retail (Highest CAGR Segment)
• Supermarkets
• Pharmacies

Analysis by Application

Preventive wellness applications held the largest share of the market in 2025, as everyday maintenance powders, chews and functional treats designed to support ongoing digestive balance in otherwise healthy pets vastly outnumber products positioned strictly for clinical intervention. This reflects the wider shift among Australian pet owners toward preventive rather than reactive care, with daily gut-support routines increasingly viewed alongside flea, tick and joint care as a standard part of responsible pet ownership rather than a response to an existing problem.

Therapeutic management is projected to grow at the fastest CAGR through 2034, driven by rising veterinary diagnosis of chronic gastrointestinal conditions such as inflammatory bowel disease, food sensitivities and antibiotic-associated dysbiosis in an ageing Australian pet population. Investment by multinational manufacturers in clinically validated technologies, including Hill's ActivBiome+ and Royal Canin's prebiotic-fortified veterinary diets, is expanding the range of conditions that can be managed nutritionally, encouraging veterinarians to prescribe therapeutic gut health formulations earlier and more frequently than in the past.

Application categories include

• Preventive Wellness (Dominating Segment)
• Therapeutic Management (Highest CAGR Segment)

By Region

Australia Pet Gut Health Market Share 2025, by Region

North America

xx%

South America

xx%

Europe

xx%

Middle East Africa

xx%

Asia Pacific

xx%

New South Wales held the largest share of the Australia Pet Gut Health Market in 2025, driven by the state's status as Australia's most populous market and its concentration of pet nutrition manufacturing and corporate infrastructure, including Blackmores' Sydney head office and Nestle Purina PetCare's Blayney production facility. Sydney and its surrounding metropolitan area host a dense network of veterinary clinics, pet specialty retailers and premium pharmacy chains such as Chemist Warehouse, giving New South Wales the broadest retail footprint for both veterinary-channel therapeutic diets and mass-retail probiotic powders. The state's high concentration of Australian-founded gut-health brands, including Ipromea, Petz Park and Purrlys, further reinforces its role as the commercial and innovation centre of the category, supported by consistent enforcement of Australian Standard AS 5812 manufacturing requirements.

Queensland is projected to record the fastest CAGR in the Australia Pet Gut Health Market through 2034, reflecting the state's above-national-average population growth as interstate migration continues to favour South East Queensland's Brisbane, Gold Coast and Sunshine Coast corridors. This inbound population growth is directly increasing pet ownership rates and the number of new veterinary clinics opening across the region, expanding the base of pet owners exposed to preventive gut-health advice for the first time. Queensland's warmer, humid climate also supports strong demand for shelf-stable postbiotic and synbiotic formats over refrigerated live-culture products, aligning with the category's fastest-growing product type and giving Queensland-focused retailers and formulators a distinct climate-driven growth advantage relative to the cooler southern states.

Regions Covered

• New South Wales (Dominating Region)
• Victoria
• Queensland (Fastest-Growing Region)
• Western Australia
• South Australia
• Rest of Australia 

Market Share

The Australia Pet Gut Health Market is fragmented, combining a small number of large multinational pet food manufacturers with a growing base of Australian-founded specialist supplement and functional-food brands. Mars Petcare (Royal Canin, Advance), Nestle Purina PetCare (Pro Plan, FortiFlora) and Colgate-Palmolive's Hill's Pet Nutrition dominate the therapeutic, veterinary-channel segment through clinically validated diets and strong veterinarian relationships, while Australian companies such as Zamipet, Talentail, Natural Pet Solutions and Vetalogica lead the mass-retail and direct-to-consumer wellness segment with locally manufactured, Australian-owned formulations. Key success factors include veterinary endorsement, TGA- and AS 5812-aligned manufacturing credentials, and ingredient traceability, while leading companies are prioritising postbiotic and synbiotic innovation, native-ingredient differentiation and expansion from clinic-only distribution into pet specialty and online retail to capture the fastest-growing parts of the category.

Key Players

• Mars, Incorporated (United States)
• Nestlé S.A. (Switzerland)
• Colgate-Palmolive Company (United States)
• Kirin Holdings Company, Limited (Japan)
• ADM Protexin Ltd (United Kingdom)
• The Microbiome Research Group (TMR) Pty Ltd (Australia)
• Talentail Australia Pty Ltd (Australia)
• Bavaria Pty Ltd (Australia)
• Nose to Tail Pet Pty Ltd (Australia)
• Vetalogica Australia Pty Ltd (Australia)
• Vitamals Management Pty Ltd (Australia)
• ZamiPet Pty Ltd (Australia)
• International Animal Health Products Pty Ltd (Australia)
• Petmima (Australia)
• Natural Pet Supplements Australia (Australia)
• Nourish Pet Co. Pty Ltd (Australia)
• Evolution Animal Care Pty Ltd (Australia)
• Viper Services Pty Ltd (Australia)

Recent Market Developments

• In January 2025, Hill's Pet Nutrition (Colgate-Palmolive) unveiled ActivBiome+ Multi-Benefit technology at VMX 2025, extending microbiome-targeted prebiotic fibre blends across its Prescription Diet and Science Diet ranges, including formulations sold in Australia through Hill's Pet Australia, reinforcing multinational investment in clinically backed gut health nutrition.
• In May 2025, Royal Canin, a Mars Petcare brand present in the Australian market through veterinary and pet specialty channels, launched a new biotics-powered pet supplement line featuring Saccharomyces boulardii CNCM I-1079 in powder and soft-chew formats, coinciding with the inaugural National Pet Wellness Day and expanding the brand's gut-health portfolio beyond its existing Gastrointestinal veterinary diets.
• In May 2025, The Pet Food Industry Association of Australia published updated industry and consumer guidance reinforcing manufacturer compliance with Australian Standard AS 5812 for pet food safety, manufacturing and labelling, explicitly linking food-safety compliance to gut microbiome health messaging for Australian pet owners.
• In November 2025, Swedish probiotics group Probi AB launched Pets by Probi, a new digestive- and oral-health ingredient platform built on its clinically studied LP6595 strain, widening the pool of pet-specific probiotic ingredients available to Australian contract manufacturers and private-label pet supplement brands through regional distribution. 

Frequently Asked Questions

Key Questions Answered

Request a Sample

1

What are probiotics, prebiotics, postbiotics and synbiotics in pet nutrition?

2

What is the CAGR of the Australia Pet Gut Health Market?

3

Which distribution channel leads the Australia Pet Gut Health Market?

4

Which application segment dominates the Australia Pet Gut Health Market?

5

What role does Australian Standard AS 5812 play in the market?

6

What are the latest trends in the Australia Pet Gut Health Market?

7

Who are the end users of pet gut health products in Australia?

Why Choose IG Transformation

Speak to Analyst

Strong Industry Focus

Extensive Product Offerings

Customer Research Services

Robust Research Methodology

Comprehensive Reports

Latest Technological Developments

Value Chain Analysis

Potential Market Opportunities

Growth Dynamics

Quality Assurance

Post-sales Support

Regular Report Updates